Transgenomic Operating Margin 2010-2023 | PRPO
Current and historical operating margin for Transgenomic (PRPO) over the last 10 years. The current operating profit margin for Transgenomic as of December 31, 2023 is -47.46%.
| Transgenomic Operating Margin Historical Data |
| Date |
TTM Revenue |
TTM Operating Income |
Operating Margin |
| 2023-12-31 |
$0.02B |
$-0.01B |
-43.75% |
| 2023-09-30 |
$0.01B |
$-0.01B |
-57.14% |
| 2023-06-30 |
$0.01B |
$-0.01B |
-90.91% |
| 2023-03-31 |
$0.01B |
$-0.01B |
-111.11% |
| 2022-12-31 |
$0.01B |
$-0.01B |
-150.00% |
| 2022-09-30 |
$0.01B |
$-0.01B |
-162.50% |
| 2022-06-30 |
$0.01B |
$-0.01B |
-150.00% |
| 2022-03-31 |
$0.01B |
$-0.01B |
-150.00% |
| 2021-12-31 |
$0.01B |
$-0.01B |
-112.50% |
| 2021-09-30 |
$0.01B |
$-0.01B |
-100.00% |
| 2021-06-30 |
$0.01B |
$-0.01B |
-100.00% |
| 2021-03-31 |
$0.01B |
$-0.01B |
-114.29% |
| 2020-12-31 |
$0.01B |
$-0.01B |
-133.33% |
| 2020-09-30 |
$0.01B |
$-0.01B |
-200.00% |
| 2020-06-30 |
$0.00B |
$-0.01B |
-250.00% |
| 2020-03-31 |
$0.00B |
$-0.01B |
-250.00% |
| 2019-12-31 |
$0.00B |
$-0.01B |
-250.00% |
| 2019-09-30 |
$0.00B |
$-0.01B |
-275.00% |
| 2019-06-30 |
$0.00B |
$-0.01B |
-325.00% |
| 2019-03-31 |
$0.00B |
$-0.01B |
-325.00% |
| 2018-12-31 |
$0.00B |
$-0.01B |
-325.00% |
| 2018-09-30 |
$0.00B |
$-0.02B |
-450.00% |
| 2018-06-30 |
$0.00B |
$-0.02B |
-600.00% |
| 2018-03-31 |
$0.00B |
$-0.02B |
-850.00% |
| 2017-12-31 |
$0.00B |
$-0.02B |
-1600.00% |
| 2017-09-30 |
$0.00B |
$-0.01B |
-500.00% |
| 2017-06-30 |
$0.00B |
$-0.00B |
-100.00% |
| 2017-03-31 |
$0.00B |
0 |
0.00% |
| 2016-12-31 |
$0.00B |
$-0.00B |
-50.00% |
| 2016-09-30 |
$0.00B |
$-0.00B |
-400.00% |
| 2016-06-30 |
$0.00B |
$-0.01B |
-600.00% |
| 2016-03-31 |
$0.00B |
$-0.01B |
inf% |
| 2015-12-31 |
$0.00B |
$-0.01B |
-800.00% |
| 2015-09-30 |
$-0.02B |
$-0.01B |
33.33% |
| 2015-06-30 |
$-0.01B |
$-0.01B |
63.64% |
| 2015-03-31 |
$-0.00B |
$-0.01B |
225.00% |
| 2014-12-31 |
$0.00B |
$-0.01B |
-1100.00% |
| 2014-09-30 |
$0.02B |
$-0.02B |
-69.57% |
| 2014-06-30 |
$0.03B |
$-0.02B |
-65.38% |
| 2014-03-31 |
$0.03B |
$-0.02B |
-61.54% |
| 2013-12-31 |
$0.03B |
$-0.02B |
-59.26% |
| 2013-09-30 |
$0.03B |
$-0.02B |
-53.57% |
| 2013-06-30 |
$0.03B |
$-0.01B |
-41.38% |
| 2013-03-31 |
$0.03B |
$-0.01B |
-32.26% |
| 2012-12-31 |
$0.03B |
$-0.01B |
-25.81% |
| 2012-09-30 |
$0.03B |
$-0.01B |
-15.15% |
| 2012-06-30 |
$0.03B |
$-0.00B |
-9.09% |
| 2012-03-31 |
$0.03B |
$-0.00B |
-12.50% |
| 2011-12-31 |
$0.03B |
$-0.00B |
-9.38% |
| 2011-09-30 |
$0.03B |
$-0.00B |
-14.29% |
| 2011-06-30 |
$0.02B |
$-0.01B |
-20.83% |
| 2011-03-31 |
$0.02B |
$-0.00B |
-19.05% |
| 2010-12-31 |
$0.02B |
$-0.00B |
-15.79% |
| 2010-09-30 |
$0.02B |
$-0.00B |
-9.52% |
| 2010-06-30 |
$0.02B |
$-0.00B |
-4.55% |
| 2010-03-31 |
$0.02B |
$-0.00B |
-4.55% |
| 2009-12-31 |
$0.02B |
$-0.00B |
-9.09% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.009B |
$0.015B |
|
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
|
